2-(Tributylstannyl)pyrazine → (R)-3'-(4-(Pyrazin-2-yl)furan-2-yl)spiro[1-azabicyclo[2.2.2]octan-3,5'-oxazolidin]-2'-one

HRID 2109459Notes

Reaction equation

HRID 2109459 reaction equation
Br[C:2]1[CH:3]=[C:4]([N:7]2[CH2:11][C@:10]3([CH:16]4[CH2:17][CH2:18][N:13]([CH2:14][CH2:15]4)[CH2:12]3)[O:9][C:8]2=[O:19])[O:5][CH:6]=1.C([Sn](CCCC)(CCCC)[C:25]1[CH:30]=[N:29][CH:28]=[CH:27][N:26]=1)CCC>>[N:26]1[CH:27]=[CH:28][N:29]=[CH:30][C:25]=1[C:2]1[CH:3]=[C:4]([N:7]2[CH2:11][C@:10]3([CH:16]4[CH2:17][CH2:18][N:13]([CH2:14][CH2:15]4)[CH2:12]3)[O:9][C:8]2=[O:19])[O:5][CH:6]=1

Participants

3

Reactant 2

HCID 27373162-(Tributylstannyl)pyrazineHCID 57634256(R)-3'-(4-Bromofuran-2-yl)spiro[1-azabicyclo[2.2.2]octan-3,5'-oxazolidin]-2'-one

Product 1

HCID 57634230(R)-3'-(4-(Pyrazin-2-yl)furan-2-yl)spiro[1-azabicyclo[2.2.2]octan-3,5'-oxazolidin]-2'-one

Procedure

The title compound was prepared by a method analog to that described in Example 14 from (R)-3′-(4-bromofuran-2-yl)spiro[1-azabicyclo[2.2.2]octan-3,5′-oxazolidin]-2′-one and 2-(tri-n-butylstannyl)pyrazine. The title compound (2 mg) was obtained as a pale solid, m/z 327 (MH+).

Workup

  1. customThe title compound was prepared by a method analog to

Sources & evidence

ORD record
ord-9f7d470331b041b985a5be8a51512de8
Source dataset
uspto-grants-2009_04
Patent number
US07514567B2

Reaction notes

Loading…